FIELD: medicine.
SUBSTANCE: invention refers to pharmacy, namely identification, estimation of quality and safety of original and reproduced medical products. Described comparative estimation of physiological activity of original medical products and reproduced medical products or related preparations implies that by means of EPR spectroscopy and spin probes influence of these products on erythrocyte, lymphocyte and thrombocyte membrane structures released of the same blood sample depending on active component concentration in solution and contact time are examined by comparison of corresponding data obtained within concentration corresponding to maximum therapeutic dose.
EFFECT: method enables comparing of pharmaceutical preparations - originals and generics, or pharmaceutical substances, with various impurity compounds, both within quality assessment and from the point of safety for patients.
3 ex, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTITUMOUR AGENT FOR TREATING PROSTATE CANCER IN THE FORM OF SACHET | 2018 |
|
RU2695326C1 |
PHARMACEUTICAL COMPOSITION POSSESSING ANTIAGGREGANT ACTIVITY | 2019 |
|
RU2709017C1 |
USE OF DIOXYDINE AS ANTI-TUMORAL MEANS | 2006 |
|
RU2325162C1 |
PROTEIN-POLYPEPTIDE COMPLEX (PPC) POSSESSING TISSUE SPECIFIC REPAIR AND REJUVENATING ACTION ON SKIN TISSUE, METHOD FOR PREPARING PROTEIN-POLYPEPTIDE COMPLEX POSSESSING TISSUE SPECIFIC REPAIR AND REJUVENATING ACTION ON SKIN TISSUE, AND PHARMACEUTICAL COMPOSITION OF PPC POSSESSING ANTIHYPOXIC, IMMUNOMODULATORY, TISSUE SPECIFIC REPAIR AND REJUVENATING ACTION ON SKIN TISSUE AND MUCOUS MEMBRANES, WITH REJUVENATING EFFECT | 2011 |
|
RU2460736C1 |
PHARMACEUTICAL COMPOSITION WITH ANTI-INFLAMMATORY ACTION | 2022 |
|
RU2801579C1 |
USE OF A PHARMACEUTICAL COMPOSITION WITH ANTIOXIDANT, VIRUCIDAL, IMMUNOSTULATING, ANTIHYPOXIC AND ANTI-AGGREGANT EFFECT | 2023 |
|
RU2808445C1 |
CHEMICAL COMPOUND BIOLOGICAL ACTIVITY DETERMINATION METHOD | 0 |
|
SU918854A1 |
COMPOSITION ON THE BASIS OF THE PRAZIQUANTEL FOR THE TREATMENT OF OPISTHORCHOSIS | 2017 |
|
RU2681649C1 |
PHARMACEUTICAL COMPOSITION AND METHOD OF OBTAINING ANTIONCOLOGIC FRACTIONS OF BLOOD SERUM (AF BS) | 2009 |
|
RU2426548C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING CENTRAL AND PERIPHERAL NERVOUS SYSTEM DISORDERS OF CARDIOVASCULAR, TRAUMATIC, TOXIC, HYPOXIC AND AUTOIMMUNE GENESIS | 2010 |
|
RU2445106C1 |
Authors
Dates
2008-07-20—Published
2007-03-21—Filed